Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

EEM vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, EEM returned +16.3% to XBI's +41.2%, and XBI charges 0.35% to EEM's 0.72%.

askIQ about this page

askIQ about EEM and XBI

Net assets on Oct 27, 2026: $29.1bn for iShares MSCI Emerging Markets ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
+16.3%
EEM total return, 1 year
+41.2%
XBI total return, 1 year
0.72%
EEM expense ratio
0.35%
XBI expense ratio

Pair scorecard

XBI costs 0.37 points a year less; their one-year returns differ by 24.9 points; EEM is 2.8 times larger.

EEM vs XBI: Differences, Returns & Fees
MeasureEEMXBI
Return
Total return, 1 year+16.3%+41.2%
Drawdown
Below its high10.8%, high on Jun 22, 2026
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksMSCI Emerging Markets IndexBiotech
Cost and size
Expense ratio0.72%0.35%
Net assets, as of Oct 27, 2026$29.1bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
Top ten holdings, share of the fund37.2%18%

Holdings in common uses holdings dated Oct 27, 2026. Method

What they share

0%

By the books each fund has filed, EEM and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first EEM XBI
Only in one fund ↓
Only in EEM
TAIWAN SEMICONDUCTOR MANUFACTURING 15.98%
SAMSUNG ELECTRONICS LTD 6.88%
SK HYNIX 4.91%
TENCENT HOLDINGS 2.64%
ALIBABA GROUP HOLDING 1.82%
MEDIATEK 1.54%
CHINA CONSTRUCTION BANK CORP H 0.94%
SAMSUNG ELECTRONICS NON VOTING PRE 0.91%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

EEM iShares MSCI Emerging Markets ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Stock ETF Thematic ETF
What it is Tracks an index of Emerging markets Biotech
Total return, 1 year +16.3% +41.2%
Expense ratio 0.72% 0.35%
Already in the S&P 500 0.0% 13.2%
Holdings 1186 165
Net assets, as of Oct 27, 2026 $29.1bn $10.3bn

EEM and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

EEM and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
EEM

EEM tracks an index of Emerging markets. Over the year to Oct 28, 2026 it returned +16.3% with distributions reinvested. The prospectus expense ratio is 0.72% a year. By its holdings published by its issuer for Oct 27, 2026, 0% of the fund by weight is stocks the S&P 500 also holds, across 1,186 positions, with the top ten at 37.2%. It sat 10.8% below its high of Jun 22, 2026 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are EEM and XBI in the same category?
EEM is a stock ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, EEM or XBI?
In the year to Oct 28, 2026, with distributions reinvested, EEM returned +16.3% and XBI +41.2%.
Which is cheaper, EEM or XBI?
XBI is cheaper, by 0.37 percentage points a year. That is about $37 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do EEM and XBI overlap with the S&P 500?
By their latest filed holdings, 0% of EEM and 13% of XBI by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, EEM against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/eem-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.